Related Experiment Video
Updated: May 23, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors
Ragini Kudchadkar1, Karl Lewis, Rene Gonzalez
1Moffitt Cancer Center, Tampa, FL 33612, USA. Ragini.kudchadkar@moffitt.org
Abstract:
Basal cell carcinoma (BCC) is the most common tumor of the skin and can result in significant morbidity as well as costs. The discovery of aberrant Hedgehog (HH) signaling in patients with genetic propensity to develop BCCs has resulted in a better understanding of the genetic abnormalities leading to the development of BCC. The current state of knowledge with regard to the genetics of BCC is discussed. Existing therapies are reviewed, in particular new targeted therapies to the HH signaling pathway that have resulted in a landmark breakthrough for patients with refractory BCC. Data from recent and ongoing trials are presented.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Renewal of Skin Epidermal Stem Cells

